You are here: Home » Companies » News
Business Standard

Sun Pharma to acquire Japan's Pola Pharma for $1 million for derma products

Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama, with capabilities to manufacture topical products and injectables

Press Trust of India  |  New Delhi 

Sun Pharma

on Monday said it would acquire Japan-based for $1 million to strengthen its presence in dermatology segment across the globe.

The firm has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan, said.

Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama, with capabilities to manufacture topical products and injectables.

First Published: Mon, November 26 2018. 17:05 IST
RECOMMENDED FOR YOU